--- title: "Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions" description: "MEDevice Boston 2025 will feature keynote sessions led by Liza Davis and Ann Roy from Boston Scientific, focusing on innovations in endoscopy, and Leonie Rynn from Johnson & Johnson MedTech, discussin" type: "news" locale: "en" url: "https://longbridge.com/en/news/258549416.md" published_at: "2025-09-23T14:00:01.000Z" --- # Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions > MEDevice Boston 2025 will feature keynote sessions led by Liza Davis and Ann Roy from Boston Scientific, focusing on innovations in endoscopy, and Leonie Rynn from Johnson & Johnson MedTech, discussing patient-centered design in medical devices. The event, scheduled for September 30 - October 1, 2025, at the Boston Convention & Exhibition Center, aims to connect OEMs with suppliers and partners, highlighting trends in the growing $886.80 billion medical device market. The conference will also include workshops, networking opportunities, and discussions on AI, FDA regulations, and supply chain strategies. BOSTON, MA / ACCESS Newswire / September 23, 2025 / **MEDevice Boston**, the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote speakers for the 2025 conference. The event will take place September 30 - October 1, at the Boston Convention & Exhibition Center (BCEC). This year's keynote sessions will feature prominent thought leaders in healthcare advancements and device development, sharing insights on the future of MedTech and strategies for success in an evolving healthcare landscape. The global medical device market size is estimated to grow to over 886.80 billion by 2032, and the United States continues to lead in the industry with the contribution of over 40% of the global revenue. Taking place in one of the top MedTech hubs in the country, MEDevice Boston reflects the energy of one of the world's most influential healthcare hubs. Setting the stage is Liza Davis, Vice President, R&D for Endoscopy at Boston Scientific, and Ann Roy, Vice President, Health Economics and Market Access, Endoscopy at Boston Scientific with the presentation "Meaningful Innovation in Endoscopy for Patient Care." The session will cover the current landscape of endoscopic technologies, recent advancements and their impact on supporting physicians and helping transform patient care, emphasizing the importance of a physician and patient-centered approach in the sector and the role of health economics to ensure access to care. On October 1, Leonie Rynn, Chief Safety Officer at Johnson & Johnson MedTech, will lead the keynote "Patient-Centered Innovation: Transforming the Future of Design and Development of Medical Devices" presenting global trends reshaping the MedTech landscape and how patients are emerging as powerful stakeholders, more informed, engaged and vocal in their healthcare journey. In parallel, regulators, payers and healthcare professionals are demanding greater trust, transparency and evidence-based innovation. Rynn will also highlight how a closed-loop safety system that leverages insights from clinical and post-market environments can inform early design decisions, close critical information gaps and ultimately deliver safer, more effective products. "MEDevice Boston continues to bring together enterprising speakers who represent the cutting edge of medical device innovation," says Adrienne Zepeda, Group Event Director, Informa Markets Engineering. "Their expertise and forward-thinking perspectives will provide invaluable insights to our attendees to foster new ideas that will push the sector forward." In addition to the keynotes, **MEDevice Boston** will feature a reimagined conference program spanning AI-enabled devices, FDA Quality Management System Regulation (QMSR) updates, global supply chain strategies, crowdfunding for startups, fireside chats with industry leaders and immersive hands-on workshops in 3D printing, human factors and AI powered clinical insights. Networking remains a hallmark of the event, with curated meetups, investor-startup matchmaking and quick connect sections on the expo floor, where exhibitors will showcase technologies and solutions shaping the future of MedTech. The opportunities, paired with an educational program designed to address both strategic and tactical challenges, create an environment where ideas move rapidly from conversation to collaboration. For more information on the keynote session, visit: www.medeviceboston.com. Register today at www.medeviceboston.com/register **About Informa Markets Engineering** Informa Markets Engineering, a subsidiary of Informa plc (LON:INF), portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit informamarkets.com. **Media Contact** Informa Markets Engineering EngineeringPR@informa.com **SOURCE:** INFORMA MARKETS - ENGINEERING View the original press release on ACCESS Newswire ### Related Stocks - [BSX.US - Boston Scientific](https://longbridge.com/en/quote/BSX.US.md) - [JNJ.US - Johnson & Johnson](https://longbridge.com/en/quote/JNJ.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 強生｜10-K：2025 財年營收 942 億美元超過預期 | | [Link](https://longbridge.com/en/news/275658131.md) | | 關鍵事實：強生在滑石粉案件中被判負有責任；已對貸款人提起 3,000 萬美元的訴訟 | 賓夕法尼亞州的陪審團裁定強生公司對其滑石粉嬰兒粉與癌症相關的責任，判給原告 25 萬美元。該公司計劃上訴，目前有超過 67,000 起類似的訴訟。Smith Law Firm 已對貸款方提起訴訟，涉及 3000 萬美元的貸款，聲稱他們的目標 | [Link](https://longbridge.com/en/news/275986663.md) | | 【新股 IPO】【認購情況】【不斷更新】人工智能 (AI) 公司海致科技 (2706) 錄得 1509.84 億元孖展，超購逾 1934 倍 | 人工智慧公司海致科技於 2 月 5 日至 10 日進行招股，截至 9 日累計錄得 1509.84 億元孖展認購，超購逾 1934 倍。公司計劃發行 2803 萬股 H 股，招股價介乎 25.6 元至 28 元，集資最多 7.8 億元，預計於 | [Link](https://longbridge.com/en/news/275394225.md) | | Censia AI 任命 Peter M. Fasolo 加入董事會，以加強企業轉型的勞動力智能層 | Censia AI 已任命 Peter M. Fasolo 為其董事會成員，以增強其勞動力智能能力。Fasolo 曾擔任強生的首席人力資源官，擁有豐富的全球人才戰略和組織轉型經驗。他的角色將專注於指導 Censia 的使命，即改善勞動力決策 | [Link](https://longbridge.com/en/news/275025270.md) | | 以「仁心、安心、貼您心」實踐 ESG 仁安醫院推動綠色醫療與社區共融 | 仁安醫院自 1995 年成立以來，秉承「仁心、安心、貼您心」的核心價值，致力於提供優質醫療服務並推動可持續發展。醫院將環境、社會與企業管治視為長期發展支柱，通過制度化管理與社區參與落實「綠色醫療」。醫院重視人才培養與企業文化，積極參與醫療認 | [Link](https://longbridge.com/en/news/274898676.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.